AM-1220
id:
am-1220-276-12338114
title:
AM-1220
text:
AM-1220 is a drug that acts as a potent and moderately selective agonist for the cannabinoid receptor CB1, with around 19 times selectivity for CB1 over the related CB2 receptor. It was originally invented in the early 1990s by a team led by Thomas D'Ambra at Sterling Winthrop, but has subsequently been researched by many others, most notably the team led by Alexandros Makriyannis at the University of Connecticut. The (piperidin-2-yl)methyl side chain of AM-1220 contains a stereocenter, so there
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/AM-1220
date created:
date modified:
2022-05-29T07:54:54Z
main entity:
{"identifier":"Q4652479","url":"https://www.wikidata.org/entity/Q4652479"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/90/AM-1220_structure.png","width":812,"height":1140}
fields total:
13
integrity:
15